Beacon Pointe Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Beacon Pointe Advisors's DXCM Position: Q1 2026 in Review
Beacon Pointe Advisors increased its DexCom (DXCM) stake by 19% in Q1 2026, buying an estimated $82.5K and bringing the position to 7,307 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.
Beacon Pointe Advisors first reported a position in DXCM in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.4M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Beacon Pointe Advisors held 7,307 shares of DexCom worth $459K as of Q1 2026.
- Beacon Pointe Advisors bought 1,185 DexCom shares in Q1 2026, an estimated $82.5K.
- DexCom made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #1341 holding.
- Beacon Pointe Advisors first reported a position in DexCom in Q2 2021 and has held it in 20 quarters since.
- Beacon Pointe Advisors's DexCom position peaked at $3.4M in Q3 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.